Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

Eur J Clin Pharmacol · 2020 · PMC7419465 · PMID 32488333

Europe PMC DOI

hedged sentence

0.0660

closest p · 1.3× alpha

0.0660

boldest claim

The sentences

close to significancep = 0.066so close (0.05 < p ≤ 0.1)

This group-by-time interaction effect was close to significance ( p = 0.066).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.